An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM).
2011 ◽
Vol 29
(15_suppl)
◽
pp. 3520-3520
◽
C. Moulton
◽
M. N. Levine
◽
C. Law
◽
R. Hart
◽
L. Ruo
◽
...